Winner Medical Co., Ltd. (SHE:300888)
China · Delayed Price · Currency is CNY 27.43
+0.11 (0.40%)
Jun 18, 2026, 3:04 PM CST
Winner Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Winner Medical stock has a consensus rating of "Strong Buy" and an average price target of ¥41.19. The average 1-year stock price forecast is 50.16% higher than the current stock price, while the lowest is ¥37.00 (+34.89%) and the highest is ¥45.75 (+66.79%).
Price Target: ¥41.19 (+50.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Winner Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 5 |
Financial Forecast
Revenue This Year
12.15B
from 10.95B
Increased by 10.94%
Revenue Next Year
13.58B
from 12.15B
Increased by 11.81%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.4B | ||
| Avg | 12.1B | ||
| Low | 11.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.2% | ||
| Avg | 10.9% | ||
| Low | 8.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |